Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Pharmacy Costs topic
No spam. Unsubscribe anytime.
Subcommittee lays bill on the table to consider capping out-of-pocket cost for epinephrine autoinjectors
Summary
Delegate Jones introduced HB 1670 to cap out-of-pocket costs for epinephrine injectors at $60; the subcommittee laid the bill on the table and recommended referral to the Health Benefit Review Commission given mandate and cost questions.
Delegate Jones introduced HB 1670 to cap out-of-pocket cost sharing for epinephrine autoinjectors (EpiPens) at $60 for individuals covered by health plans in Virginia. The sponsor framed the bill as a consumer affordability measure modeled on a law in Illinois and said the cost cap would standardize pricing and make life-saving medication more affordable and predictable for families.
Why it matters: Testimony highlighted the high retail cost for EpiPens and the impact on families with severe allergies. Industry witnesses told the committee this is one of several cost-sharing-restriction proposals and recommended referral to HERC for study as a mandate with potential budget implications. Doug Gray of the insurance industry pointed to existing work at HERC, the need to consider high-deductible plan exemptions consistent with IRS rules, and potential application to the State Health Plan.
Delegate Sullivan moved to lay the bill on the table and request that the chair send it to HERC for consideration; the motion passed by recorded vote, 7-0. The committee record reflects that the committee will seek HERC analysis before further action.
